Immunotope is seeking commercial partnerships with  biotechnology and pharmaceutical companies that develop immunotherapeutic vaccines, monoclonal antibody therapeutics and diagnostic tests for cancer and infectious diseases.

Antigens available for outlicensing

We have a variety of novel antigens available for clinical evaluation and outlicensing:

• Lung cancer antigens

• Pancreatic cancer antigens

• Platinum resistant ovarian cancer antigens

• Antibody therapeutic targets

• Cancer diagnostic targets